Back to GNLXGENELUX Corp (GNLX)View full pipeline
Non-platinum chemotherapy: paclitaxel or nab-paclitaxel for squamous cell NSCLC or pemetrexed for nonsquamous cell NSCLC
Phase 2Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Advanced Non-squamous Non-small-cell Lung Cancer
View Full LandscapeDrug Information
Target Indication
Advanced Non-squamous Non-small-cell Lung Cancer
Clinical Trial
NCT06463665Last updated: 10/21/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Platinum chemotherapy: carboplatin (preferred) or cisplatinPhase 3
Platinum-resistant Ovarian Cancer
olvimulogene nanivacirepvecPhase 3
Platinum-resistant Ovarian Cancer
GL-ONC1Phase 2
Peritoneal Carcinomatosis
platinum (cisplatin or carboplatin)Phase 2
SCLC, Extensive Stage
Platinum-doublet with or without bevacizumabPhase 2
Ovarian Cancer
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts